Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).
The global Molecular Residual Disease Detection market size is projected to grow from US$ 4578.2 million in 2023 to US$ 13080 million in 2030; it is expected to grow at a CAGR of 16.2% from 2024 to 2030.
The 鈥淢olecular Residual Disease Detection Industry Forecast鈥� looks at past sales and reviews total world Molecular Residual Disease Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Molecular Residual Disease Detection sales for 2024 through 2030. With Molecular Residual Disease Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Residual Disease Detection industry.
This Insight Report provides a comprehensive analysis of the global Molecular Residual Disease Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Residual Disease Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Molecular Residual Disease Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Residual Disease Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Residual Disease Detection.
United States market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Molecular Residual Disease Detection players cover Adaptive, Guardant Health, Invitae, Cergentis B.V and LexentBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Residual Disease Detection market by product type, application, key players and key regions and countries.
Segmentation by type
Tumor-informed Assays
Tumor-agnostic Assays
Segmentation by application
Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Residual Disease Detection Market Size 2019-2030
2.1.2 Molecular Residual Disease Detection Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Residual Disease Detection Segment by Type
2.2.1 Tumor-informed Assays
2.2.2 Tumor-agnostic Assays
2.3 Molecular Residual Disease Detection Market Size by Type
2.3.1 Molecular Residual Disease Detection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular Residual Disease Detection Market Size Market Share by Type (2019-2024)
2.4 Molecular Residual Disease Detection Segment by Application
2.4.1 Prognosis
2.4.2 Adjuvant Treatment Decision-Making
2.4.3 Surveillance for Postoperative Recurrence
2.4.4 Other
2.5 Molecular Residual Disease Detection Market Size by Application
2.5.1 Molecular Residual Disease Detection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular Residual Disease Detection Market Size Market Share by Application (2019-2024)
3 Molecular Residual Disease Detection Market Size by Player
3.1 Molecular Residual Disease Detection Market Size Market Share by Players
3.1.1 Global Molecular Residual Disease Detection Revenue by Players (2019-2024)
3.1.2 Global Molecular Residual Disease Detection Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Residual Disease Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Residual Disease Detection by Regions
4.1 Molecular Residual Disease Detection Market Size by Regions (2019-2024)
4.2 Americas Molecular Residual Disease Detection Market Size Growth (2019-2024)
4.3 APAC Molecular Residual Disease Detection Market Size Growth (2019-2024)
4.4 Europe Molecular Residual Disease Detection Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Residual Disease Detection Market Size Growth (2019-2024)
5 Americas
5.1 Americas Molecular Residual Disease Detection Market Size by Country (2019-2024)
5.2 Americas Molecular Residual Disease Detection Market Size by Type (2019-2024)
5.3 Americas Molecular Residual Disease Detection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Residual Disease Detection Market Size by Region (2019-2024)
6.2 APAC Molecular Residual Disease Detection Market Size by Type (2019-2024)
6.3 APAC Molecular Residual Disease Detection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Residual Disease Detection by Country (2019-2024)
7.2 Europe Molecular Residual Disease Detection Market Size by Type (2019-2024)
7.3 Europe Molecular Residual Disease Detection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Residual Disease Detection by Region (2019-2024)
8.2 Middle East & Africa Molecular Residual Disease Detection Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Residual Disease Detection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Residual Disease Detection Market Forecast
10.1 Global Molecular Residual Disease Detection Forecast by Regions (2025-2030)
10.1.1 Global Molecular Residual Disease Detection Forecast by Regions (2025-2030)
10.1.2 Americas Molecular Residual Disease Detection Forecast
10.1.3 APAC Molecular Residual Disease Detection Forecast
10.1.4 Europe Molecular Residual Disease Detection Forecast
10.1.5 Middle East & Africa Molecular Residual Disease Detection Forecast
10.2 Americas Molecular Residual Disease Detection Forecast by Country (2025-2030)
10.2.1 United States Molecular Residual Disease Detection Market Forecast
10.2.2 Canada Molecular Residual Disease Detection Market Forecast
10.2.3 Mexico Molecular Residual Disease Detection Market Forecast
10.2.4 Brazil Molecular Residual Disease Detection Market Forecast
10.3 APAC Molecular Residual Disease Detection Forecast by Region (2025-2030)
10.3.1 China Molecular Residual Disease Detection Market Forecast
10.3.2 Japan Molecular Residual Disease Detection Market Forecast
10.3.3 Korea Molecular Residual Disease Detection Market Forecast
10.3.4 Southeast Asia Molecular Residual Disease Detection Market Forecast
10.3.5 India Molecular Residual Disease Detection Market Forecast
10.3.6 Australia Molecular Residual Disease Detection Market Forecast
10.4 Europe Molecular Residual Disease Detection Forecast by Country (2025-2030)
10.4.1 Germany Molecular Residual Disease Detection Market Forecast
10.4.2 France Molecular Residual Disease Detection Market Forecast
10.4.3 UK Molecular Residual Disease Detection Market Forecast
10.4.4 Italy Molecular Residual Disease Detection Market Forecast
10.4.5 Russia Molecular Residual Disease Detection Market Forecast
10.5 Middle East & Africa Molecular Residual Disease Detection Forecast by Region (2025-2030)
10.5.1 Egypt Molecular Residual Disease Detection Market Forecast
10.5.2 South Africa Molecular Residual Disease Detection Market Forecast
10.5.3 Israel Molecular Residual Disease Detection Market Forecast
10.5.4 Turkey Molecular Residual Disease Detection Market Forecast
10.5.5 GCC Countries Molecular Residual Disease Detection Market Forecast
10.6 Global Molecular Residual Disease Detection Forecast by Type (2025-2030)
10.7 Global Molecular Residual Disease Detection Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Adaptive
11.1.1 Adaptive Company Information
11.1.2 Adaptive Molecular Residual Disease Detection Product Offered
11.1.3 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Adaptive Main Business Overview
11.1.5 Adaptive Latest Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Information
11.2.2 Guardant Health Molecular Residual Disease Detection Product Offered
11.2.3 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Guardant Health Main Business Overview
11.2.5 Guardant Health Latest Developments
11.3 Invitae
11.3.1 Invitae Company Information
11.3.2 Invitae Molecular Residual Disease Detection Product Offered
11.3.3 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Invitae Main Business Overview
11.3.5 Invitae Latest Developments
11.4 Cergentis B.V
11.4.1 Cergentis B.V Company Information
11.4.2 Cergentis B.V Molecular Residual Disease Detection Product Offered
11.4.3 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cergentis B.V Main Business Overview
11.4.5 Cergentis B.V Latest Developments
11.5 LexentBio
11.5.1 LexentBio Company Information
11.5.2 LexentBio Molecular Residual Disease Detection Product Offered
11.5.3 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 LexentBio Main Business Overview
11.5.5 LexentBio Latest Developments
11.6 Natera
11.6.1 Natera Company Information
11.6.2 Natera Molecular Residual Disease Detection Product Offered
11.6.3 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Natera Main Business Overview
11.6.5 Natera Latest Developments
11.7 BGI
11.7.1 BGI Company Information
11.7.2 BGI Molecular Residual Disease Detection Product Offered
11.7.3 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BGI Main Business Overview
11.7.5 BGI Latest Developments
11.8 Zhiben Medical
11.8.1 Zhiben Medical Company Information
11.8.2 Zhiben Medical Molecular Residual Disease Detection Product Offered
11.8.3 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Zhiben Medical Main Business Overview
11.8.5 Zhiben Medical Latest Developments
11.9 Burning Rock Medicine
11.9.1 Burning Rock Medicine Company Information
11.9.2 Burning Rock Medicine Molecular Residual Disease Detection Product Offered
11.9.3 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Burning Rock Medicine Main Business Overview
11.9.5 Burning Rock Medicine Latest Developments
11.10 Huidu Medical
11.10.1 Huidu Medical Company Information
11.10.2 Huidu Medical Molecular Residual Disease Detection Product Offered
11.10.3 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Huidu Medical Main Business Overview
11.10.5 Huidu Medical Latest Developments
11.11 Zhenhe Technology
11.11.1 Zhenhe Technology Company Information
11.11.2 Zhenhe Technology Molecular Residual Disease Detection Product Offered
11.11.3 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Zhenhe Technology Main Business Overview
11.11.5 Zhenhe Technology Latest Developments
11.12 ExactSciences
11.12.1 ExactSciences Company Information
11.12.2 ExactSciences Molecular Residual Disease Detection Product Offered
11.12.3 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 ExactSciences Main Business Overview
11.12.5 ExactSciences Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
